GigXR partners with NUS Medicine to deliver holographic clinical scenarios for Gastroenterology training

06 May 2023

NUS Yong Loo Lin School of Medicine receives $6 million gift for Yeo Boon Khim Mind Science Centre

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has been gifted $6 million for the Mind Science Centre, an academic research centre under NUS Medicine, by Mr Lin Tah Hwa. The Centre will be named the Yeo Boon Khim Mind Science Centre in honor of Mr Lin's late mother, Madam Yeo Boon Khim, in gratitude of the generous gift.

26 Apr 2023

Building Resilience is Key to Good Mental Health: NUS Youth Epidemiology and Resilience Study

With data collected over the COVID-19 pandemic period from 2020 to 2022, the NUS Youth Epidemiology and Resilience (YEAR) study involved 3,336 young people aged 10 to 18 and describes the association of resilience, risks, and protective factors in developing internalising and externalising symptoms, and how resilience mitigates mental health distress.

24 Apr 2023

Red blood cell particles are effective drug carriers in suppressing muscle loss caused by cancer: NUS study

A study demonstrated that vesicles released by red blood cells are a viable platform for delivering drugs to increase muscle growth and suppress cancer-associated skeletal muscle weakening and loss.

19 Apr 2023

Digital Peer Emotional Support Improves Youth Well-being: NUS study

In a study led by the Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and digital peer support platform, Acceset, it was found that peer support via a digital platform enhanced the well-being of youth, with reduction of self-reported depression and anxiety symptoms after the intervention. Of note, digital peer support lowered depressive and anxiety symptoms in emerging adults following intervention, by nearly 40%, compared to symptoms prior to intervention. The effect of the intervention was sustained beyond the period of the intervention, for approximately six weeks.

17 Apr 2023

NUS researchers uncover new differences in bacteria’s sugar coat to aid pneumococcal vaccine development

In a ground-breaking discovery by scientists at the Yong Loo Lin School of Medicine, the structures, type of linkages and combinations of the sugar layer called the capsular polysaccharide (CPS), which encases many disease-causing bacteria like Streptococcus pneumoniae, matter greatly in allowing the bacteria to better attach and survive on the lining of the upper and lower human respiratory tracts.

14 Apr 2023

NUS researchers report potential new treatment for leaky gut using milk-derived extracellular vesicles

It is unclear whether milk-derived extracellular vesicles (mEVs) protect the gut barrier and treat leaky gut. To this end, Assistant Professor Jiong-Wei Wang of NUS Medicine's Nanomedicine Translational Research Programme and Centre for NanoMedicine, in collaboration with Professor Huaxi Yi of Ocean University of China, led a research team to investigate the potential treatment effects of mEVs on the leaky gut.

05 Apr 2023

Tuberculosis patients see dramatic cut in treatment duration, treatment effectiveness remains

In a study conducted across Asia and Uganda, Africa, the research team led by Professor Nicholas Paton from NUS Medicine, NUH, and Singapore SCRI discovered that a TB treatment strategy with an initial 8-week treatment period, followed by retreatment of a small minority who were not cured, showed the same efficacy level as the standard 6-month treatment.

25 Mar 2023

Zeroing In On Population Eye Health Care

The new Centre for Innovation and Precision Eye Health at NUS Medicine aims to improve the overall eye health of the population though bringing greater eye care accessibility to the community, tapping on AI and data science to understand and detect eye diseases and investing in gene and cell therapy to treat rare eye diseases.

22 Mar 2023

Unmasking the secret of broadly neutralising COVID-19 therapeutic antibodies

It is still uncertain whether new emerging variants of the COVID-19 disease can escape the protective immune response triggered by vaccines and whether pre-existing antibodies present in patients who have recovered from COVID-19 can neutralise them. Homing in on this, Associate Professor Justin Chu, Director of the Biosafety Level 3 (BSL-3) Core Facility and Associate Professor in the Department of Microbiology and Immunology, and Infectious Diseases Translational Research Programme at NUS Medicine, led a joint study conducted by the BSL-3 Core Facility and Tsinghua University in China, to investigate how broadly neutralising antibodies acquire their ability to neutralise all variants of SARS-CoV-2 tested.

21 Mar 2023

Promoting healthy longevity should start young: pregnancy complications lift women’s risk of mortality in the next 50 years

Pregnancy is a critical reproductive event for women, with substantial life-long health implications. Homing in on this, Prof Zhang Cuilin from NUS Medicine Department of Obstetrics and Gynecology led a collaborative study to investigate the question on how having pregnancy complications may inform one’s long-term mortality risk, relative to those without the complications.